Forced Registration Makes Flimsy Suit, Mylan Tells Fed. Circ.
By Michael Macagnone ( January 4, 2016, 5:44 PM EST) -- Mylan Pharmaceuticals pushed a Federal Circuit panel on Monday to toss a Delaware federal suit alleging it violated rival Acorda's drug patents with a generic drug application, maintaining the state's mandatory business registration doesn't justify a suit moving forward as there is already another pending case on the issue....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.